CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Systemic therapy for advanced hepatocellular carcinoma: consideration for selecting second-line treatment
Bo Hyun Kim, Joong-Won Park
J Liver Cancer. 2021;21(2):124-138.   Published online September 30, 2021
DOI: https://doi.org/10.17998/jlc.2021.09.23

Excel Download

Systemic therapy for advanced hepatocellular carcinoma: consideration for selecting second-line treatment
Journal of Liver Cancer. 2021;21(2):124-138   Crossref logo
Link1 Link2 Link3

Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma
Journal of Hepatocellular Carcinoma. 2016;Volume 3:31-36   Crossref logo
Link1

Regorafenib as Second-Line Systemic Therapy May Change the Treatment Strategy and Management Paradigm for Hepatocellular Carcinoma
Liver Cancer. 2016;5(4):235-244   Crossref logo
Link1 Link2

Ramucirumab as Second-Line Systemic Therapy in Hepatocellular Carcinoma
Liver Cancer. 2018;7(4):305-311   Crossref logo
Link1 Link2

PD-(L)1 inhibitors vs targeted therapy vs their combination as second-line treatment in patients with advanced hepatocellular carcinoma previously treated with sorafenib
Annals of Oncology. 2019;30:iv105   Crossref logo
Link1 Link2 Link3

Second-Line Treatment Options for Hepatocellular Carcinoma: Current Landscape and Future Direction
Journal of Hepatocellular Carcinoma. 2021;Volume 8:1147-1158   Crossref logo
Link1 Link2

Management of Hepatocellular Carcinoma after Progression on First-Line Systemic Treatment: Defining the Optimal Sequencing Strategy in Second Line and Beyond
Current Oncology. 2020;27(13):173-180   Crossref logo
Link1 Link2 Link3

Comprehensive Consideration before the Decision-Making of the Systemic Treatment in Patients with Advanced Hepatocellular Carcinoma
Liver Cancer. 2019;9(2):221-222   Crossref logo
Link1 Link2

Hepatic reserve and the other conditions for regorafenib as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib in Japanese practical setting
Annals of Oncology. 2017;28:x71   Crossref logo
Link1 Link2 Link3

Second-line docetaxel-based chemotherapy after failure of fluorouracil-based first-line treatment for advanced esophageal squamous cell carcinoma
OncoTargets and Therapy. 2014;1875   Crossref logo
Link1